首页> 外国专利> Compounds derived from pirazolopiridina Hydrogenated P2X7 Inhibitors, Pharmaceutical composition that comprises; Preparation Process; and their use in the treatment of Bone Diseases,SNS, cardiovascular, among others (Divisional cl 2655 - 2015)

Compounds derived from pirazolopiridina Hydrogenated P2X7 Inhibitors, Pharmaceutical composition that comprises; Preparation Process; and their use in the treatment of Bone Diseases,SNS, cardiovascular, among others (Divisional cl 2655 - 2015)

机译:衍生自吡唑并吡咯烷酮氢化的P2X7抑制剂的化合物,药物组合物,包含:制备过程;及其在治疗骨骼疾病,SNS,心血管疾病等方面的用途(分部cl 2655-2015)

摘要

4,5,6,7-tetrahydro-1h-pyridine-4,5-c-pyridine compound, P2X7 modulator, can be used for the treatment of rheumatoid arthritis, osteoarthritis, cortitis, chemical shock, allergic dermatitis, asthma, specific pulmonary fibrosis, nephritis, EPOC, nervous system diseases and neuroimmune system diseases, Acute chronic neuralgia, inflammation, etc.
机译:4,5,6,7-四氢-1h-吡啶-4,5-c-吡啶化合物,P2X7调节剂,可用于治疗类风湿性关节炎,骨关节炎,皮质炎,化学休克,过敏性皮炎,哮喘,特异性肺纤维化,肾炎,EPOC,神经系统疾病和神经免疫系统疾病,急性慢性神经痛,炎症等。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号